Stock data

奈米醫材 (6612)

奈米醫材 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$110.94M, up 36.0% from a year earlier. EPS over the last four quarters totals NT$1.91.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 奈米醫材 in Insightr